Profound early control of highly pathogenic SIV by an effector-memory T cell vaccine

[1]  N. Sardesai,et al.  Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaques. , 2011, Vaccine.

[2]  A. Haase,et al.  Early events in sexual transmission of HIV and SIV and opportunities for interventions. , 2011, Annual review of medicine.

[3]  Ruchi M. Newman,et al.  TRIM5 Suppresses Cross-Species Transmission of a Primate Immunodeficiency Virus and Selects for Emergence of Resistant Variants in the New Species , 2010, PLoS biology.

[4]  Ashley T. Haase,et al.  Targeting early infection to prevent HIV-1 mucosal transmission , 2010, Nature.

[5]  J. Sodroski,et al.  TRIM5α Modulates Immunodeficiency Virus Control in Rhesus Monkeys , 2010, PLoS pathogens.

[6]  R. Schinazi,et al.  Viral Sanctuaries during Highly Active Antiretroviral Therapy in a Nonhuman Primate Model for AIDS , 2009, Journal of Virology.

[7]  D. Montefiori,et al.  DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge , 2009, Proceedings of the National Academy of Sciences.

[8]  L. Picker,et al.  Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis , 2009, The Journal of experimental medicine.

[9]  R. Siliciano,et al.  A Simian Immunodeficiency Virus-Infected Macaque Model To Study Viral Reservoirs That Persist during Highly Active Antiretroviral Therapy , 2009, Journal of Virology.

[10]  L. Picker,et al.  Effector-memory T cell responses are associated with protection of rhesus monkeys from mucosal SIV challenge , 2009, Nature Medicine.

[11]  D. Burton,et al.  Macaques vaccinated with live-attenuated SIV control replication of heterologous virus , 2008, The Journal of experimental medicine.

[12]  D. Montefiori,et al.  Immune Control of an SIV Challenge by a T Cell-Based Vaccine in Rhesus Monkeys , 2008, Nature.

[13]  Philip J. R. Goulder,et al.  Impact of MHC class I diversity on immune control of immunodeficiency virus replication , 2008, Nature Reviews Immunology.

[14]  K. Reimann,et al.  Reduced Protection from Simian Immunodeficiency Virus SIVmac251 Infection Afforded by Memory CD8+ T Cells Induced by Vaccination during CD4+ T-Cell Deficiency , 2008, Journal of Virology.

[15]  C. Mathis,et al.  Longitudinal in vivo positron emission tomography imaging of infected and activated brain macrophages in a macaque model of human immunodeficiency virus encephalitis correlates with central and peripheral markers of encephalitis and areas of synaptic degeneration. , 2008, The American journal of pathology.

[16]  Hui Li,et al.  Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection , 2008, Proceedings of the National Academy of Sciences.

[17]  Z. Grossman,et al.  Progressive CD4+ central–memory T cell decline results in CD4+ effector–memory insufficiency and overt disease in chronic SIV infection , 2007, The Journal of Experimental Medicine.

[18]  Z. Grossman,et al.  Progressive CD4+ central–memory T cell decline results in CD4+ effector–memory insufficiency and overt disease in chronic SIV infection , 2007, The Journal of experimental medicine.

[19]  D. Watkins,et al.  Subdominant CD8+ T-Cell Responses Are Involved in Durable Control of AIDS Virus Replication , 2007, Journal of Virology.

[20]  Yan Zhou,et al.  Novel Pathway for Induction of Latent Virus from Resting CD4+ T Cells in the Simian Immunodeficiency Virus/Macaque Model of Human Immunodeficiency Virus Type 1 Latency , 2006, Journal of Virology.

[21]  R. Siliciano,et al.  Isolation and Characterization of Replication-Competent Human Immunodeficiency Virus Type 1 from a Subset of Elite Suppressors , 2006, Journal of Virology.

[22]  Jiang Fan,et al.  Vaccine-Induced Cellular Immune Responses Reduce Plasma Viral Concentrations after Repeated Low-Dose Challenge with Pathogenic Simian Immunodeficiency Virus SIVmac239 , 2006, Journal of Virology.

[23]  Gary J. Nabel,et al.  Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged Monkeys , 2006, Science.

[24]  D. Watkins,et al.  Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag , 2005, Journal of Virology.

[25]  A. Haase.  Perils at mucosal front lines for HIV and SIV and their hosts , 2005, Nature Reviews Immunology.

[26]  J. Lifson,et al.  Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS , 2005, Journal of medical primatology.

[27]  D. Montefiori,et al.  DNA Vaccines Expressing Different Forms of Simian Immunodeficiency Virus Antigens Decrease Viremia upon SIVmac251 Challenge , 2005, Journal of Virology.

[28]  H. Robinson,et al.  T cell vaccines for microbial infections , 2005, Nature Medicine.

[29]  D. Montefiori,et al.  Evaluating Neutralizing Antibodies Against HIV, SIV, and SHIV in Luciferase Reporter Gene Assays , 2004, Current protocols in immunology.

[30]  P. Barry,et al.  Cloning of the Full-Length Rhesus Cytomegalovirus Genome as an Infectious and Self-Excisable Bacterial Artificial Chromosome for Analysis of Viral Pathogenesis , 2003, Journal of Virology.

[31]  R. Siliciano,et al.  Resting CD4+ T Lymphocytes but Not Thymocytes Provide a Latent Viral Reservoir in a Simian Immunodeficiency Virus-Macaca nemestrina Model of Human Immunodeficiency Virus Type 1-Infected Patients on Highly Active Antiretroviral Therapy , 2003, Journal of Virology.

[32]  C. Macken,et al.  Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects , 2003, AIDS.

[33]  C. Pitcher,et al.  Development and Homeostasis of T Cell Memory in Rhesus Macaque1 , 2002, The Journal of Immunology.

[34]  P. Klenerman,et al.  A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[35]  D. Richman,et al.  Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue. , 1999, AIDS.

[36]  T. Chun,et al.  Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R P Johnson,et al.  Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. , 1998, Science.

[38]  R. Zinkernagel,et al.  Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[39]  B. Trapnell,et al.  Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy , 1996, Journal of virology.

[40]  M. Perricaudet,et al.  In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium , 1992, Cell.

[41]  M. Baseler,et al.  Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp120 binding, even in the presence of enhancing antibodies , 1990, The Journal of experimental medicine.

[42]  M. Merkenschlager,et al.  Memory T cells , 1989, Nature.

[43]  L. Picker,et al.  Addendum: Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge , 2011, Nature Network Boston.

[44]  R. Ahmed,et al.  Persistent viral infections. , 1999 .